Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
Clinical trial NCT02256917 · COMPLETED
Trial details
- NCT number
- NCT02256917
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-09-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.